Abdullah Yusuf

Abdullah Yusuf

Abdullah Yusuf leads market intelligence research at Salient Advisory, a global health consulting firm, where he helps advise governments, pharma companies, and global health institutions on scaling health products across Africa. He is trained as a pharmacist, holds an MPH from Boston University, an MBA from IE Business School, and worked previously at BCG and IQVIA.

Latest Articles

A revolutionary HIV drug won't matter if patients can't afford it

A revolutionary HIV drug won't matter if patients can't afford it

3 months ago // Opinion: Global health

Opinion: Getting lenacapavir to patients who need it requires engaging health facilities in the private sector. Supply chain startups could make the breakthrough drug more accessible by lowering the costs of distribution to a wider range of facilities.